Bluejay Diagnostics BJDX
NASDAQ BJDX
$2.47 +0.15 (+6.47%)
At close: Nov 9, 2026 · 4:00 PM EST

Bluejay Diagnostics (BJDX) Gross Profit (2022)

Updated

Bluejay Diagnostics (BJDX) posted Gross Profit of $48,911 for FY2022.

Analysis

Bluejay Diagnostics (BJDX) Gross Profit (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn
10 Bluejay Diagnostics 5.18 Mn -16.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 48,911.00
API Access

Bluejay Diagnostics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=BJDX&period=max&api_key=YOUR_API_KEY